514 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
GSK GlaxoSmithKline PLC $38.2 $94.7B Buy
Wall Street Breakfast: Futures Slip As Shutdown Continues https://seekingalpha.com/article/4139030-wall-street-breakfast-futures-slip-shutdown-continues?source=feed Jan 22, 2018 - As the government shutdown enters a third day, U.S. futures are edging down, the dollar is pulling back slightly and Treasury yields are touching 3 1/2-year highs. We have to see if this event is a t
Better Buy: GlaxoSmithKline plc vs. Eli Lilly https://www.fool.com/investing/2018/01/21/better-buy-glaxosmithkline-plc-vs-eli-lilly.aspx?source=iedfolrf0000001 Jan 21, 2018 - Both big pharma stocks have growth drivers. But both also come with baggage.
Stocks To Watch: Earnings Season Hits Higher Gear https://seekingalpha.com/article/4138856-stocks-watch-earnings-season-hits-higher-gear?source=feed Jan 20, 2018 - Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
Will J&J's (JNJ) Pharma Segment Pull Up its Q4 Earnings? http://www.zacks.com/stock/news/289469/will-jjs-jnj-pharma-segment-pull-up-its-q4-earnings?cid=CS-ZC-FT-289469 Jan 19, 2018 - J&J's (JNJ) pharma segment sales growth accelerated in the third quarter and we are likely to see, a continuation of the positive trend in the fourth quarter.
Pharma Stock Roundup: Merck's Keytruda Shines in Study, Priority Review for Kymriah Label Expansion http://www.zacks.com/stock/news/289357/pharma-stock-roundup-mercks-keytruda-shines-in-study-priority-review-for-kymriah-label-expansion?cid=CS-ZC-FT-289357 Jan 18, 2018 - Focus this week was on Merck's (MRK) data on Keytruda as well as Novartis's updates on Kymriah and its biosimilar efforts.
J&J (JNJ) Hits New 52-Week High: What's Driving the Stock? http://www.zacks.com/stock/news/289278/jj-jnj-hits-new-52-week-high-whats-driving-the-stock?cid=CS-ZC-FT-289278 Jan 18, 2018 - Promising data from several pivotal studies and a rapid pipeline progress contribute to a rally in Johnson & Johnson's (JNJ) shares.
J&J (JNJ) to Set Pharma Q4 Earnings in Motion: What's Up? http://www.zacks.com/stock/news/289265/jj-jnj-to-set-pharma-q4-earnings-in-motion-whats-up?cid=CS-ZC-FT-289265 Jan 18, 2018 - The positive trend seen in J&J's (JNJ) pharma segment sales in Q3 is likely to continue in Q4. Strong pharma performance and contribution from acquisitions should support the top line.
Novo Nordisk: Don't Spoil The Ablynx Acquisition https://seekingalpha.com/article/4138149-novo-nordisk-spoil-ablynx-acquisition?source=feed_sector_healthcare Jan 17, 2018 - Novo Nordisk has made a $3.1B bid on the Belgian biotech Ablynx.The Danish insulin giant needs acquisitions to turn to growth again.There are probably more pharma giants interested in Ablynx.Ablynx's
7 Stocks Move in Premarket Trade Wednesday http://www.gurufocus.com/news/625187/7-stocks-move-in-premarket-trade-wednesday Jan 17, 2018 - 7 Stocks Move in Premarket Trade Wednesday, Stocks: ATEN,MRK,GSK,GE,HOG,QCOM,NURO, release date:Jan 17, 2018
Stocks For 2018: Beaten Down, With Dividends, And Recession Resistant https://seekingalpha.com/article/4137805-stocks-2018-beaten-dividends-recession-resistant?source=feed_all_articles Jan 16, 2018 - After an 8-year bull run, I am looking to invest in stocks that will sustain revenues if the economic cycle turns south.I want to own stocks that pay a dividend so that even if the market crashes, I c

Pages: 123456...52

Page 1>

Related Companies

Name Exchange Price Mkt Cap
LLY Eli Lilly and Company NYSE $85.49 $94.13B
AZN Astrazeneca PLC NYSE $35.44 $89.75B
BMY Bristol-Myers Squibb Company NYSE $62.28 $101.93B
ABT Abbott Laboratories NYSE $59.31 $103.24B
CELG Celgene Corporation NASDAQ $102.65 $80.82B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for GlaxoSmithKline PLC
GSK - Google Finance https://www.google.com/finance?q=GSK Industry related info and international coverage Summary News
GSK - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=GSK Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options